RxDoctor Payments Data

Glenn Brothers, DO

Family Medicine · Travelers Rest, SCNPI 1871549055

Payments from drug & device makers

$744in general payments, 2019–2025

Across 32 payments — averaging $23.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$319
  • Lilly USA, LLC$84
  • Amgen$81
  • Novo Nordisk$54
  • Bayer$45
  • Abbott$41
  • plus $119 from 6 others

What the payments were for

  • Food & beverage$744100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$744 in reported general payments places this provider in the 55th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$153,923
Medicare patients
371
Services billed
1,472

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin261$210,988
OzempicSemaglutide182$174,959
MounjaroTirzepatide101$105,819
EliquisApixaban120$102,128
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog69$77,143
JanuviaSitagliptin Phosphate56$63,090
Trelegy ElliptaFluticasone/Umeclidin/Vilanter52$37,926
XareltoRivaroxaban35$34,848
Tresiba Flextouch U-200Insulin Degludec30$27,091
Breo ElliptaFluticasone/Vilanterol42$24,645
RybelsusSemaglutide25$23,077
MyrbetriqMirabegron17$11,168
TrintellixVortioxetine Hydrobromide11$8,781
Stiolto RespimatTiotropium Br/Olodaterol Hcl18$8,382
Albuterol Sulfate HfaAlbuterol Sulfate257$8,115

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Stiolto Respimat$28$219,370279 claims
Novo NordiskOzempic, Rybelsus$54$198,036207 claims
Lilly USA, LLCMounjaro$84$105,819101 claims
PfizerEliquis$14$102,128120 claims
AbbVieSynthroid$319$6,36780 claims
AstraZenecaSymbicort$20$5,79516 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Travelers Rest

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →